VaxDesign Corp., sanofi-aventis deal

sanofi-aventis' Sanofi Pasteur S.A. vaccines division will acquire VaxDesign for up to $60 million in cash. VaxDesign uses its Modular IMune In-vitro Construct (MIMIC) technology to develop in vitro ...